PL2381923T3 - Donosowe podawanie desmopresyny - Google Patents

Donosowe podawanie desmopresyny

Info

Publication number
PL2381923T3
PL2381923T3 PL09796558T PL09796558T PL2381923T3 PL 2381923 T3 PL2381923 T3 PL 2381923T3 PL 09796558 T PL09796558 T PL 09796558T PL 09796558 T PL09796558 T PL 09796558T PL 2381923 T3 PL2381923 T3 PL 2381923T3
Authority
PL
Poland
Prior art keywords
desmopressin administration
intranasal desmopressin
intranasal
administration
desmopressin
Prior art date
Application number
PL09796558T
Other languages
English (en)
Inventor
Seymour Fein
Original Assignee
Serenity Pharmaceuticals Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42168193&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2381923(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Serenity Pharmaceuticals Llc filed Critical Serenity Pharmaceuticals Llc
Publication of PL2381923T3 publication Critical patent/PL2381923T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/02—Sprayers or atomisers specially adapted for therapeutic purposes operated by air or other gas pressure applied to the liquid or other product to be sprayed or atomised
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/08—Inhaling devices inserted into the nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/08—Inhaling devices inserted into the nose
    • A61M15/085—Fixing means therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/27—General characteristics of the apparatus preventing use
    • A61M2205/276—General characteristics of the apparatus preventing use preventing unwanted use
PL09796558T 2008-12-22 2009-12-21 Donosowe podawanie desmopresyny PL2381923T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13987108P 2008-12-22 2008-12-22
PCT/US2009/068962 WO2010075266A2 (en) 2008-12-22 2009-12-21 Safe desmopressin administration
EP09796558.6A EP2381923B2 (en) 2008-12-22 2009-12-21 Intranasal desmopressin administration

Publications (1)

Publication Number Publication Date
PL2381923T3 true PL2381923T3 (pl) 2019-04-30

Family

ID=42168193

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09796558T PL2381923T3 (pl) 2008-12-22 2009-12-21 Donosowe podawanie desmopresyny

Country Status (19)

Country Link
US (3) US20120015880A1 (pl)
EP (2) EP3437633A1 (pl)
JP (4) JP5731396B2 (pl)
KR (2) KR101755042B1 (pl)
CN (2) CN105963834A (pl)
AU (1) AU2009330203B2 (pl)
BR (1) BRPI0923557A2 (pl)
CA (1) CA2747998C (pl)
DK (1) DK2381923T4 (pl)
EA (2) EA201791732A1 (pl)
ES (1) ES2692345T5 (pl)
IL (1) IL213699A (pl)
MX (1) MX2011006765A (pl)
NZ (1) NZ593613A (pl)
PL (1) PL2381923T3 (pl)
PT (1) PT2381923T (pl)
SG (2) SG172344A1 (pl)
WO (1) WO2010075266A2 (pl)
ZA (1) ZA201105420B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2472539C2 (ru) * 2007-08-06 2013-01-20 Аллерган, Инк. Способы и устройства для доставки препарата десмопрессина
CA2747998C (en) * 2008-12-22 2016-05-31 Allergan, Inc. Safe desmopressin administration
KR101792696B1 (ko) * 2009-06-18 2017-11-02 알레간 인코포레이티드 안전한 데스모프레신 투여
DK3024474T3 (da) 2013-07-23 2022-03-28 Serenity Pharmaceuticals Llc Sammensætninger omfattende desmopressin i kombination med en beta-3-adrenoreceptor-agonist
WO2015013453A1 (en) 2013-07-23 2015-01-29 Allergan, Inc. Methods and compositions comprising desmopressin in combination with a 5-alpha reductase inhibitor
KR20170097045A (ko) 2014-11-20 2017-08-25 알레간 인코포레이티드 알파-아드레날린성 수용체 길항제와 조합된 데스모프레신을 포함하는 방법 및 조성물

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS171787B1 (pl) 1973-11-09 1976-11-29
US4148787A (en) 1976-05-24 1979-04-10 Ferring Ab Antidiuretically effective polypeptide and a process for preparing the same
US4771769A (en) 1982-12-20 1988-09-20 Schering Corporation Hand held metered spray dispenser
US4746508A (en) 1983-06-06 1988-05-24 Beth Israel Hospital Assn. Drug administration
US4548922A (en) 1983-06-06 1985-10-22 Beth Israel Hospital Drug administration
US5731303A (en) 1985-12-04 1998-03-24 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery compositions
US5023252A (en) * 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US5112804A (en) 1987-04-01 1992-05-12 Temple University Of The Commonwealth System Of Higher Education Pharmaceutical composition and method of intranasal administration
US4944429A (en) 1987-08-28 1990-07-31 Schering Corporation Manually-operable spray dispenser with locking mechanism
US5154122A (en) 1989-10-20 1992-10-13 Sol Goldschmidt Shipping device for suspended piece goods
CN1060980A (zh) * 1990-10-26 1992-05-13 蔡东林 多用电控自控微型喷雾器
US5314694A (en) 1990-10-29 1994-05-24 Alza Corporation Transdermal formulations, methods and devices
US5122383A (en) 1991-05-17 1992-06-16 Theratech, Inc. Sorbitan esters as skin permeation enhancers
US5227169A (en) 1991-05-17 1993-07-13 Theratech, Inc. Sorbitan esters as skin permeation enhancers
US5212199A (en) 1991-05-17 1993-05-18 Theratech, Inc. Sorbitan esters as skin permeation enhancers
IT1255895B (it) 1992-10-20 1995-11-17 Laura Chiodini Composizioni farmaceutiche contenenti una calcitonina
HU221617B1 (hu) * 1993-06-29 2002-12-28 Ferring B.V. Vizes készítmény dezmopresszin nazális adagolására
EP0840630B1 (en) * 1995-06-07 2009-05-06 O'NEIL, Christine Patient controlled drug delivery device
US5763398A (en) * 1996-06-20 1998-06-09 Ferring B.V. Nasal administration of desmopressin
DE19723133A1 (de) 1997-06-03 1998-12-10 Caideil M P Teoranta Tourmakea Austragvorrichtung für Medien
US7335186B2 (en) 1998-03-13 2008-02-26 Alexander George Brian O'Neil Patient controlled drug delivery device
EP1071517B1 (de) 1999-02-14 2008-04-02 Ing. Erich Pfeiffer GmbH Spender für fliessfähige medien
DE19938798A1 (de) 1999-08-16 2001-03-01 Pfeiffer Erich Gmbh & Co Kg Spender für Flüssigkeiten oder für zähflüssige oder versprühbare Produkte
DE19940236A1 (de) 1999-08-25 2001-03-08 Pfeiffer Erich Gmbh & Co Kg Spender mit manuell betätigbarer Ausbringeinrichtung
DE10110742A1 (de) 2001-02-28 2002-09-05 Pfeiffer Erich Gmbh & Co Kg Spender für Medien
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
CN1283365C (zh) 2001-09-21 2006-11-08 艾里希普费弗工程师有限公司 具有一个介质容器和用于该容器的泵机构的配量装置
EP1458353A1 (en) 2001-12-19 2004-09-22 ALZA Corporation Formulation dosage form for the controlled delivery of ther apeutic agents
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
ITMI20021684A1 (it) * 2002-07-29 2004-01-29 Therapicon Srl Composizione farmaceutica di peptide nasale
US7186692B2 (en) * 2002-12-17 2007-03-06 Nastech Pharmaceutical Company Inc. Compositions and methods for enhanced mucosal delivery and non-infused administration of Y2 receptor-binding peptides and methods for treating and preventing obesity
EP2322195A2 (en) * 2003-11-10 2011-05-18 Reprise Biopharmaceutics, LLC Pharmaceutical compositions including low dosages of desmopressin
ATE474591T1 (de) 2003-12-08 2010-08-15 Cpex Pharmaceuticals Inc Pharmazeutische zusammensetzungen und verfahren für die insulinbehandlung
WO2007022345A2 (en) * 2005-08-17 2007-02-22 Fleming And Company, Pharmaceuticals Vitamin b12 nasal spray and method of use
CN1785448A (zh) * 2005-11-11 2006-06-14 广东工业大学 医用防染式药雾吸入喷嘴
CA2654207A1 (en) * 2006-06-08 2007-12-21 Cpex Pharmaceuticals, Inc. Insulin composition
CA2747998C (en) * 2008-12-22 2016-05-31 Allergan, Inc. Safe desmopressin administration
KR101792696B1 (ko) * 2009-06-18 2017-11-02 알레간 인코포레이티드 안전한 데스모프레신 투여

Also Published As

Publication number Publication date
CN105963834A (zh) 2016-09-28
CN102355888A (zh) 2012-02-15
NZ593613A (en) 2013-02-22
JP6389209B2 (ja) 2018-09-12
US20120015880A1 (en) 2012-01-19
EA028531B1 (ru) 2017-11-30
WO2010075266A2 (en) 2010-07-01
SG10201509152VA (en) 2015-12-30
AU2009330203B2 (en) 2015-09-03
ES2692345T5 (es) 2024-01-26
SG172344A1 (en) 2011-07-28
EP2381923B1 (en) 2018-08-01
EP3437633A1 (en) 2019-02-06
EP2381923B2 (en) 2023-06-07
JP2016196488A (ja) 2016-11-24
IL213699A (en) 2016-05-31
EA201170873A1 (ru) 2012-02-28
US20220126039A1 (en) 2022-04-28
EP2381923A2 (en) 2011-11-02
IL213699A0 (en) 2011-07-31
WO2010075266A3 (en) 2011-01-06
PT2381923T (pt) 2018-11-13
KR101755042B1 (ko) 2017-07-06
US20200078542A1 (en) 2020-03-12
ZA201105420B (en) 2012-04-25
JP2012513403A (ja) 2012-06-14
BRPI0923557A2 (pt) 2016-01-26
JP2018184407A (ja) 2018-11-22
JP2015127350A (ja) 2015-07-09
CA2747998C (en) 2016-05-31
EA201791732A1 (ru) 2018-03-30
KR20170081711A (ko) 2017-07-12
DK2381923T4 (da) 2023-09-11
AU2009330203A1 (en) 2011-07-14
KR20110102915A (ko) 2011-09-19
CA2747998A1 (en) 2010-07-01
DK2381923T3 (en) 2018-11-19
JP5731396B2 (ja) 2015-06-10
ES2692345T3 (es) 2018-12-03
MX2011006765A (es) 2011-11-01
JP5959076B2 (ja) 2016-08-02

Similar Documents

Publication Publication Date Title
EP2287578A4 (en) SPECTROMETER
EP2280616A4 (en) BODY FOR BABY
EP2257170A4 (en) TÉTRAHYDROFUROPYRIDONES
EP2320212A4 (en) SPECTROMETER
EP2285758A4 (en) DISPOSABLE PACKAGING FOR FERTILIZER-PESTICIDE
EP2313147A4 (en) crimping
ZA201105420B (en) Intranasal desmopressin administration
EP2233305A4 (en) GRAPHIC PRINTER
EP2268182A4 (en) BUSE
GB2457997B (en) Nozzle
EP2285375A4 (en) SPIROAZAINDOLE
EP2320211A4 (en) SPECTROMETER
GB0800389D0 (en) Gileo hang-it
GB0800161D0 (en) Rota-board
GB2465427B (en) Nozzle
GB0807949D0 (en) Easydraw drawing aid
AU4098P (en) NPW2 Dianella tasmanica
AU3977P (en) PARV01 Myoporum parvifolium
AU3935P (en) DPV308 Dianella prunina
AU3972P (en) Tobruk xTriticosecale
GB0800108D0 (en) Construct
GB0823255D0 (en) Construct
GB0823395D0 (en) None
GB0808074D0 (en) P2
GB0800410D0 (en) Q-Box